Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In addition to fatigue, pain is the most frequent persistent symptom in cancer survivors. Clear guidelines for both the diagnosis and treatment of pain in cancer survivors are lacking. Classification of pain is important as it may facilitate more specific targeting of treatment. In this paper we present an overview of nociceptive, neuropathic and central sensitization pain following cancer treatment, as well as the rationale, criteria and process for stratifying pain classification. MATERIAL AND METHODS: Recently, a clinical method for classifying any pain as either predominant central sensitization pain, neuropathic or nociceptive pain was developed, based on a large body of research evidence and international expert opinion. We, a team of 15 authors from 13 different centers, four countries and two continents have applied this classification algorithm to the cancer survivor population. RESULTS: The classification of pain following cancer treatment entails two steps: (1) examining the presence of neuropathic pain; and (2) using an algorithm for differentiating predominant nociceptive and central sensitization pain. Step 1 builds on the established criteria for neuropathic pain diagnosis, while Step 2 applies a recently developed clinical method for classifying any pain as either predominant central sensitization pain, neuropathic or nociceptive pain to the cancer survivor population. CONCLUSION: The classification criteria allow identifying central sensitization pain following cancer treatment. The recognition of central sensitization pain in practice is an important development in the integration of pain neuroscience into the clinic, and one that is relevant for people undergoing and following cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771
Neblett, R., Cohen, H., Choi, Y., Hartzell, M. M., Williams, M., Mayer, T. G., & Gatchel, R. J. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.11.012 · Cited by 757 · cited 4×
“The cutoff of 40 on the CSI allows correct identification of over 82% of central sensitization pain patients, but the chances of false-positives are relatively high, which supports our approach of combining this measure with a more comprehensive examination for identification of predominant central sensitization pain…”
BackgroundResultInfluentialTreatment of central sensitization in patients with ‘unexplained’chronic pain: An update
Nijs, J., Malfliet, A., Ickmans, K., Baert, I., & Meeus, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.925446 · Cited by 195
Self-citationFernández-Lao, C., Cantarero-Villanueva, I., Fernández-de-las-Peñas, C., Del-Moral-Ávila, R., Menjón-Beltrán, S., & Arroyo-Morales, M. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2010.01027.x · Cited by 89
Cited by
Nijs, J., Lahousse, A., Kapreli, E., Bilika, P., Saraçoğlu, İ., Malfliet, A., Coppieters, I., De Baets, L., Leysen, L., Roose, E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153203 · Cited by 430
“, whiplash) [18], fibromyalgia [19], osteoarthritis [20], migraine [21], irritable bowel syndrome [22], chronic fatigue syndrome [23], paediatric pain [24], low back pain [25], non-traumatic neck pain [26], rheumatoid arthritis [27] and pain following cancer [6].”
BackgroundInfluentialSelf-citationManfuku, M., Nishigami, T., Mibu, A., Tanaka, K., Kitagaki, K., & Sumiyoshi, K. (2019) · Breast Cancer · doi:10.1007/s12282-019-00979-y · Cited by 34
Johannsen, M., Frederiksen, Y., Jensen, A., & Zachariae, R. (2017) · Journal of Pain Research · doi:10.2147/jpr.s124665 · Cited by 22
“The majority of studies and reviews have mainly focused on the biomedical predictors of pain in breast cancer survivors (eg, Andersen and Kehlet, 5 Wang et al, 8 Nijs et al 50 ) and, so far, only two systematic reviews have examined the role of psychosocial factors, 5,14 neither of which included prospective studies o…”
Metadata
- Authors
- Nijs, J., Leysen, L., Adriaenssens, N., Aguilar Ferrándiz, M. E., Devoogdt, N., Tassenoy, A., Ickmans, K., Goubert, D., van Wilgen, C. P., Wijma, A. J., Kuppens, K., Hoelen, W., Hoelen, A., Moloney, N., & Meeus, M.
- Venue
- Acta Oncologica
- Published
- 2016-05-04
- Volume
- 55
- Issue
- 6
- Pages
- 659-663
- ISSN
- 0284-186X (ISSN-L)
- 1651-226X
- OpenAlex
- W2346974102
- Cited by
- 110
- References
- 4
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. https://app.cochat.ai/papers/10.3109/0284186x.2016.1167958
- The paper
- Nijs, J., Leysen, L., Adriaenssens, N., Aguilar Ferrándiz, M. E., Devoogdt, N., Tassenoy, A., Ickmans, K., Goubert, D., van Wilgen, C. P., Wijma, A. J., Kuppens, K., Hoelen, W., Hoelen, A., Moloney, N., & Meeus, M. (2016). Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncologica. https://doi.org/10.3109/0284186x.2016.1167958
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.